Bgm (BGM) Cash & Equivalents (2019 - 2026)
Bgm (BGM) recorded Cash & Equivalents of $11.52 million in fiscal Q2 2026 (quarter ended Mar 31, 2026), up 19.3% from $9.65 million a year earlier.
Powered by 
Analysis
Bgm (BGM) Cash & Equivalents (2019 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Bgm reported Cash & Equivalents of $9.82 million, up 119.4% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of -3.7% (FY2020 to FY2025).
- Across earlier fiscal years, Cash & Equivalents came in at $4.47 million in FY2024 (-40.1%), $7.48 million in FY2023 (-47.8%), $14.32 million in FY2022 (+13.6%) and $12.61 million in FY2021 (+6.2%).
- The fiscal Q2 2026 figure is the highest quarterly Cash & Equivalents since fiscal Q4 2022.
- On a year-over-year basis, Cash & Equivalents rose in two of the last four quarters, with growth averaging 23.0%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 119.4% in fiscal Q4 2025, against a decline of 50.1% in fiscal Q4 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Bgm | 35.00 Mn | -4,800.00 Bn | - | 11.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 11.52 Mn |
| Sep 30, 2025 | 9.82 Mn |
| Mar 31, 2025 | 9.65 Mn |
| Sep 30, 2024 | 4.47 Mn |
| Mar 31, 2024 | 10.35 Mn |
| Sep 30, 2023 | 7.48 Mn |
| Mar 31, 2023 | 9.71 Mn |
| Sep 30, 2022 | 14.98 Mn |
| Mar 31, 2022 | 16.67 Mn |
| Sep 30, 2021 | 12.61 Mn |
| Mar 31, 2021 | 20.31 Mn |
| Sep 30, 2020 | 11.87 Mn |
| Sep 30, 2019 | 4.59 Mn |
API Access
Bgm Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BGM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "BGM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BGM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();